Novartis UK is the UK affiliate of Swiss-based Novartis AG – one of the largest and most widely respected pharmaceutical companies in the world.
Novartis UK employs over 3,500 people on 14 sites. In the UK the Novartis sites are involved in manufacturing, packaging, customer service and marketing for products used in the UK and worldwide.
The Respiratory Research Centre at Horsham is the Novartis worldwide headquarters for respiratory research, employing over 300 scientists in a £42 million purpose-built centre.
Horsham is the global research centre for gastro-intestinal research for Novartis.
Novartis Vaccines facility in Liverpool is the UK’s only large-scale producer of influenza vaccines and the company is still investing heavily in new manufacturing facilities at the site.
Novartis has invested over £600 million in the Grimsby manufacturing site over the last 15 years.
Novartis treatment for patients with severe, persistent allergic asthma has been awarded a prestigious Prix Galien award for innovative research and development.